Hinecol Tablets 10 mg (Bethanechol Chloride)

Adult dose

Adults: Administer 10 ~ 25 milligrams per dose 3 ~ 4 times daily. Taking this medication immediately after meals may cause symptoms such as nausea and vomiting; therefore, taking it on an empty stomach is recommended.

If serious side effects occur after administration, atropine sulfate must be administered subcutaneously immediately. This medication should not be used in patients with mechanical obstruction in the gastrointestinal or urinary tract. Patients with spastic gastrointestinal disorders, gastric ulcers, or acute inflammatory diseases of the gastrointestinal tract should also not use this medication. This medication should not be administered to patients with peritonitis. This medication is inappropriate for patients with vagal nerve hyperactivity. This medication should be avoided in patients with asthma as it may be dangerous. This medication should not be administered to patients with hyperthyroidism. The use of this medication is prohibited in patients with coronary artery obstruction. This medication should not be administered to patients with bradycardia, heart block, or vascular instability. Patients with hypotension or hypertension should be cautious before using this medication. This medication is contraindicated in patients with myocardial infarction or severe heart disease. Patients with epilepsy or Parkinson's disease should not use this medication. Patients receiving anticholinesterase therapy should not use this medication concurrently. This medication should not be used in patients with unhealed gastrointestinal anastomosis. Pregnant women should not take this medication. This medication contains lactose, so it should not be administered to patients with genetic disorders such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. This medication contains Yellow No. 5 dye, so patients who are allergic or hypersensitive to this component should use it with caution. Taking this medication may sometimes result in gastrointestinal symptoms such as heartburn, abdominal discomfort, nausea, vomiting, gastric cramps, and diarrhea. Neurological symptoms such as sweating, flushing, and increased salivation may also occur. Cardiovascular symptoms such as palpitations or hypotension may occur, so caution is needed. In the case of overdose, severe symptoms such as cardiac arrest, fainting, transient complete heart block, respiratory distress, orthostatic hypotension, loss of consciousness with bowel movement, and urgent urination may occur. Asthma patients may experience asthma attacks, so caution is particularly necessary. This medication may interact with quinidine or procainamide when used together, so caution is advised. Cholinergic drugs, especially cholinesterase inhibitors, may enhance each other's effects when used in combination, so use carefully. Caution is particularly necessary when administered to patients taking sympatholytic agents as it may cause severe abdominal symptoms and rapid blood pressure drop. This medication must be kept out of reach of children and stored tightly closed away from direct sunlight, in a cool, dry place. To protect the quality, do not transfer to another container, and prevent misuse.

• heartburn
• abdominal discomfort
• nausea
• vomiting
• stomach cramps
• diarrhea
• sweating
• flushing
• salivation
• palpitations

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius.

Appearance

Yellow round tablets

Package unit

30 tablets/bottle, 300 tablets/bottle